Fundraising Fox
Sebacia
Duluth, US · Founded 2010 · Delaware corporation · 3 known investors
Find your way into Sebacia
Each arrow is one introduction. Sign up to fill in the first one.
247 people can intro you to Dilip
Ask Erin Keller to introduce you to Dilip Paithankar
You →Erin · together at Sebacia →Dilip
69 people can intro you to Todd
Ask Jamie Chen to introduce you to Todd Meyer
You →Jamie · together at The Innovation Factory →Todd
Sign up to find every way you can get introduced to Sebacia
- Your email: who you already know at Sebacia, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sebacia team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
TM
Todd MeyerChief Operating Officer2010–2019Todd Meyer holds an MBA and JD and has spent his career in medical technology leadership, including roles as VP of Business Development at The Innovation Factory since 2005, COO of Halscion developing surgical hydrogels, and COO/General Counsel of Sebacia. Prior to these roles, he worked as an associate at Gunderson Dettmer, a venture capital-focused law firm, and began his career in pharmaceutical sales.
DP
Dilip PaithankerExecutive
RL
Robert LeslieExecutive
DP
Dilip PaithankarExecutiveDilip Paithankar has more than twenty years in the medical device industry, focusing on therapeutic and diagnostic devices, drug delivery, and nanotechnology applications including laser-based systems. He brings experience in clinical trial design, regulatory clearance pathways, and leading product development programs.
Board
RB
Rebecca B. RobertsonBoard director
GV
Gerard van Hamel PlaterinkBoard director
JT
TD
Thomas D. WeldonBoard director
TB
Todd BradyBoard director
NW
Neal WalkerBoard director
Investors · 3
Accuitive Medical Venturesreported
How we know: funding news · Not right? Tell us
Domain AssociatesreportedPrinceton · $200K – $15Mvia Jesse Treu · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Versant VenturesreportedSan Francisco · $250K – $5M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$50.1M disclosed across 4 rounds · 2014–2019
▶$10MraisedSep 2019 · 7 investors · Other Health CareRule 506(b)
▶$10MraisedSep 2019 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rebecca S. RobertsonDirector
- Neal WalkerDirector
- Charles E. LarsonDirector
- Charles AbrahamExecutive Officer, Director
- John DyettDirector
- Jesse TreuDirector
- Offering amount
- $15M
- Amount sold
- $10M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.1MraisedJul 2017 · 6 investors · Other Health CareRule 506(b)
▶$21.1MraisedJul 2017 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert LeslieExecutive Officer
- John DyettDirector
- Anthony V. LandoExecutive Officer, Director
- Neal WalkerDirector
- Jesse TreuDirector
- Thomas D. WeldonDirector
- Rebecca B. RobertsonDirector
- Offering amount
- $26.1M
- Amount sold
- $21.1M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedJun 2015 · 6 investors · Other Health CareRule 506(b)
▶$8MraisedJun 2015 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rebecca B. RobertsonDirector
- Anthony V. LandoExecutive Officer, Director
- Gerard van Hamel PlaterinkDirector
- Todd MeyerExecutive Officer
- Jesse TreuDirector
- Thomas D. WeldonDirector
- Dilip PaithankerExecutive Officer
- Robert LeslieExecutive Officer
- Neal WalkerDirector
- Offering amount
- $12M
- Amount sold
- $8M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedJun 2014 · 6 investors · Other Health CareRule 506(b)
▶$11MraisedJun 2014 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert LeslieExecutive Officer
- Todd BradyDirector
- Anthony V. LandoExecutive Officer, Director
- Dilip PaithankarExecutive Officer
- Rebecca B. RobertsonDirector
- Thomas D. WeldonDirector
- Neal WalkerDirector
- Gerard van Hamel PlaterinkDirector
- Offering amount
- $16M
- Amount sold
- $11M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Sebacia's investors?
- Sebacia's investors include Accuitive Medical Ventures, Domain Associates, Versant Ventures.
- How much funding has Sebacia raised?
- Sebacia has disclosed $50.1M raised across 4 rounds.
- Where is Sebacia headquartered?
- Sebacia is headquartered in Duluth, US.